Search

Now showing items 1-10 of 17

Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial

Choueiri, T; Escudier, B; Powles, T; Mainwaring, P; Rini, B; Donskov, F; Hammers, H; Hutson, T; Roth, B; Peltola, K;... (2015-09)

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma

Kurtoglu, M; Davarpanah, NN; Qin, R; Powles, T; Rosenberg, JE; Apolo, AB (2015-10)

Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)

Rosenberg, J; Petrylak, D; Abidoye, O; Van der Heijden, MS; Hofman-Censits, J; Necchi, A; O'Donnell, PH; Balmanoukian, A; Loriot, Y; Retz, M;... (2015-09)

A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer

Berlato, C; Khan, MN; Schioppa, T; Thompson, R; Maniati, E; Montfort, A; Jangani, M; Canosa, M; Kulbe, H; Hagemann, UB;... (2017-03-01)

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro)

Kramar, A; Negrier, S; Sylvester, R; Joniau, S; Mulders, P; Powles, T; Bex, A; Bonnetain, F; Bossi, A; Bracarda, S;... (2015-12)

Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus

Lardas, M; Stewart, F; Scrimgeour, D; Hofmann, F; Marconi, L; Dabestani, S; Bex, A; Volpe, A; Canfield, SE; Staehler, M;... (2016-08)

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

Olson, TA; Murray, MJ; Rodriguez-Galindo, C; Nicholson, JC; Billmore, DF; Krailo, MD; Dang, HM; Amatruda, JF; Thornton, CM; Arul, GS;... (2015-09-20)

Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Bridgeman, VL; Wan, E; Foo, S; Nathan, MR; Welti, JC; Frentzas, S; Vermeulen, PB; Preece, N; Springer, CJ; Powles, T;... (2016-01)

Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer

Stewart, GD; O'Mahony, FC; Laird, A; Eory, L; Lubbock, ALR; Mackay, A; Nanda, J; O'Donnell, M; Mullen, P; McNeill, SA;... (2015-09-15)

Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma

Crusz, SM; Tang, YZ; Sarker, S-J; Prevoo, W; Kiyani, I; Beltran, L; Peters, J; Sahdev, A; Bex, A; Powles, T;... (2016-11-14)